Ballentine Partners’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$158K	Buy	14,315 +1,221	+9%	+$13.5K	﹤0.01%	907
2025 Q1	$117K	Hold	13,094	–	–	﹤0.01%	849
2024 Q4	$123K	Buy	13,094 +246	+2%	+$2.32K	﹤0.01%	823
2024 Q3	$104K	Buy	+12,848	New	+$104K	﹤0.01%	801